OMER

Omeros (OMER)

Omeros Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OMER

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	21:50	Business Wire	Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024	NASDAQ:OMER	Omeros Corporation
2024/05/09	21:50	Business Wire	Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress	NASDAQ:OMER	Omeros Corporation
2024/04/02	05:02	Business Wire	Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results	NASDAQ:OMER	Omeros Corporation
2024/03/27	21:30	Business Wire	Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024	NASDAQ:OMER	Omeros Corporation
2024/02/20	23:00	Business Wire	Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	NASDAQ:OMER	Omeros Corporation
2024/02/14	20:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OMER	Omeros Corporation
2024/02/07	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2024/02/01	23:11	Business Wire	Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust	NASDAQ:OMER	Omeros Corporation
2024/01/30	05:26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:OMER	Omeros Corporation
2023/11/22	10:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/18	11:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/16	11:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/11/10	06:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMER	Omeros Corporation
2023/11/10	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2023/11/10	06:02	Business Wire	Omeros Corporation Reports Third Quarter 2023 Financial Results	NASDAQ:OMER	Omeros Corporation
2023/11/06	22:00	Business Wire	Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023	NASDAQ:OMER	Omeros Corporation
2023/11/03	22:05	Business Wire	Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	NASDAQ:OMER	Omeros Corporation
2023/11/02	22:05	Business Wire	Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting	NASDAQ:OMER	Omeros Corporation
2023/10/19	21:30	Business Wire	Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer	NASDAQ:OMER	Omeros Corporation
2023/10/17	05:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMER	Omeros Corporation
2023/10/16	20:30	Business Wire	Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy	NASDAQ:OMER	Omeros Corporation
2023/09/28	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/28	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/28	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/09/21	05:47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OMER	Omeros Corporation
2023/09/15	08:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMER	Omeros Corporation
2023/08/10	06:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OMER	Omeros Corporation
2023/08/09	21:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMER	Omeros Corporation